BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 32248190)

  • 1. The Design of and Rationale for the Effect of Perioperative Inhaled Tiotropium for Patients with Chronic Obstructive Pulmonary Disease in Esophageal Cancer Surgery (EPITOPE): an Open-Label, Randomized, Parallel-Group Study.
    Okamura A; Watanabe M; Kitazono S; Manoshiro H; Kasama E; Takahashi K; Toihata T; Otake R; Kozuki R; Imamura Y; Yamahara Y; Ishizuka N
    Eur Surg Res; 2020; 61(4-5):123-129. PubMed ID: 32248190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized multicenter Phase II study of perioperative tiotropium intervention in gastric cancer patients with chronic obstructive pulmonary disease.
    Fushida S; Oyama K; Kaji M; Hirono Y; Kinoshita J; Tsukada T; Nezuka H; Nakano T; Noto M; Nishijima K; Fujimura T; Ohta T
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2177-83. PubMed ID: 26491284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single inhaler extrafine triple therapy versus long-acting muscarinic antagonist therapy for chronic obstructive pulmonary disease (TRINITY): a double-blind, parallel group, randomised controlled trial.
    Vestbo J; Papi A; Corradi M; Blazhko V; Montagna I; Francisco C; Cohuet G; Vezzoli S; Scuri M; Singh D
    Lancet; 2017 May; 389(10082):1919-1929. PubMed ID: 28385353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of tiotropium + olodaterol on physical functioning in COPD: results of an open-label observational study.
    Sauer R; Hänsel M; Buhl R; Rubin RA; Frey M; Glaab T
    Int J Chron Obstruct Pulmon Dis; 2016; 11():891-8. PubMed ID: 27217742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of physical functioning and handling of tiotropium/olodaterol Respimat
    Steinmetz KO; Abenhardt B; Pabst S; Hänsel M; Kondla A; Bayer V; Buhl R
    Int J Chron Obstruct Pulmon Dis; 2019; 14():1441-1453. PubMed ID: 31308649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative inspiratory muscle training to prevent postoperative pulmonary complications in patients undergoing esophageal resection (PREPARE study): study protocol for a randomized controlled trial.
    Valkenet K; Trappenburg JC; Gosselink R; Sosef MN; Willms J; Rosman C; Pieters H; Scheepers JJ; de Heus SC; Reynolds JV; Guinan E; Ruurda JP; Rodrigo EH; Nafteux P; Fontaine M; Kouwenhoven EA; Kerkemeyer M; van der Peet DL; Hania SW; van Hillegersberg R; Backx FJ
    Trials; 2014 Apr; 15():144. PubMed ID: 24767575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study Design of VESUTO
    Ichinose M; Minakata Y; Motegi T; Ueki J; Seki T; Anzai T; Takizawa A; Grönke L; Hirata K
    Adv Ther; 2017 Jul; 34(7):1622-1635. PubMed ID: 28537001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD.
    Keam SJ; Keating GM
    Treat Respir Med; 2004; 3(4):247-68. PubMed ID: 15350163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bronchodilator Effect of Tiotropium via Respimat
    Ogasawara T; Sakata J; Aoshima Y; Tanaka K; Yano T; Kasamatsu N
    Intern Med; 2017 Sep; 56(18):2401-2406. PubMed ID: 28824055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination inhaled steroid and long-acting beta2-agonist versus tiotropium for chronic obstructive pulmonary disease.
    Welsh EJ; Cates CJ; Poole P
    Cochrane Database Syst Rev; 2013 May; (5):CD007891. PubMed ID: 23728670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhaled tiotropium to prevent postoperative cardiopulmonary complications in patients with newly diagnosed chronic obstructive pulmonary disease requiring lung cancer surgery.
    Nojiri T; Inoue M; Yamamoto K; Maeda H; Takeuchi Y; Nakagiri T; Shintani Y; Minami M; Sawabata N; Okumura M
    Surg Today; 2014 Feb; 44(2):285-90. PubMed ID: 23307265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tiotropium and olodaterol in the prevention of chronic obstructive pulmonary disease exacerbations (DYNAGITO): a double-blind, randomised, parallel-group, active-controlled trial.
    Calverley PMA; Anzueto AR; Carter K; Grönke L; Hallmann C; Jenkins C; Wedzicha J; Rabe KF
    Lancet Respir Med; 2018 May; 6(5):337-344. PubMed ID: 29605624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of adding inhaled corticosteroids to tiotropium and long-acting beta(2)-agonists for chronic obstructive pulmonary disease.
    Karner C; Cates CJ
    Cochrane Database Syst Rev; 2011 Sep; 2011(9):CD009039. PubMed ID: 21901729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tiotropium in Early-Stage Chronic Obstructive Pulmonary Disease.
    Zhou Y; Zhong NS; Li X; Chen S; Zheng J; Zhao D; Yao W; Zhi R; Wei L; He B; Zhang X; Yang C; Li Y; Li F; Du J; Gui J; Hu B; Bai C; Huang P; Chen G; Xu Y; Wang C; Liang B; Li Y; Hu G; Tan H; Ye X; Ma X; Chen Y; Hu X; Tian J; Zhu X; Shi Z; Du X; Li M; Liu S; Yu R; Zhao J; Ma Q; Xie C; Li X; Chen T; Lin Y; Zeng L; Ye C; Ye W; Luo X; Zeng L; Yu S; Guan WJ; Ran P
    N Engl J Med; 2017 Sep; 377(10):923-935. PubMed ID: 28877027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary complications in patients with chronic obstructive pulmonary disease following transthoracic esophagectomy.
    Jiao WJ; Wang TY; Gong M; Pan H; Liu YB; Liu ZH
    World J Gastroenterol; 2006 Apr; 12(16):2505-9. PubMed ID: 16688794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of 12 weeks of once-daily tiotropium/olodaterol on exercise endurance during constant work-rate cycling and endurance shuttle walking in chronic obstructive pulmonary disease.
    Maltais F; O'Donnell D; Gáldiz Iturri JB; Kirsten AM; Singh D; Hamilton A; Tetzlaff K; Zhao Y; Casaburi R
    Ther Adv Respir Dis; 2018; 12():1753465818755091. PubMed ID: 29439648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tiotropium/Olodaterol Delays Clinically Important Deterioration Compared with Tiotropium Monotherapy in Patients with Early COPD: a Post Hoc Analysis of the TONADO
    Rabe KF; Chalmers JD; Miravitlles M; Kocks JWH; Tsiligianni I; de la Hoz A; Xue W; Singh D; Ferguson GT; Wedzicha J
    Adv Ther; 2021 Jan; 38(1):579-593. PubMed ID: 33175291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Tiotropium Safety and Performance in Respimat Trial (TIOSPIR), a large scale, randomized, controlled, parallel-group trial-design and rationale.
    Wise RA; Anzueto A; Calverley P; Dahl R; Dusser D; Pledger G; Koenen-Bergmann M; Joseph E; Cotton D; Disse B
    Respir Res; 2013 Apr; 14(1):40. PubMed ID: 23547660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Olodaterol + tiotropium bromide for the treatment of chronic obstructive pulmonary disease.
    Cazzola M; Rogliani P; Ora J; Matera MG
    Expert Rev Clin Pharmacol; 2015; 8(5):529-39. PubMed ID: 26294073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination inhaled steroid and long-acting beta2-agonist versus tiotropium for chronic obstructive pulmonary disease.
    Welsh EJ; Cates CJ; Poole P
    Cochrane Database Syst Rev; 2010 May; (5):CD007891. PubMed ID: 20464758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.